Royal Bank of Canada Lowers Biohaven Price Target to 66.00
SSYGX Fund | USD 43.01 0.15 0.35% |
Slightly above 52% of Dreyfus/the Boston's investor base is interested to short. The analysis of overall sentiment of trading Dreyfusthe Boston Pany mutual fund suggests that many investors are impartial at this time. Dreyfus/the Boston's investing sentiment can be driven by a variety of factors including economic data, Dreyfus/the Boston's earnings reports, geopolitical events, and overall market trends.
Dreyfus/the |
Biohaven had its price target reduced by research analysts at Royal Bank of Canada from 68.00 to 66.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an outperform rating on the stock. Royal Bank of Canadas price objective suggests a potential upside of 31.84 percent
Read at thelincolnianonline.com
Dreyfus/the Boston Fundamental Analysis
We analyze Dreyfus/the Boston's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfus/the Boston using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfus/the Boston based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Dreyfusthe Boston is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Dreyfusthe Boston Pany Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfus/the Boston mutual fund to make a market-neutral strategy. Peer analysis of Dreyfus/the Boston could also be used in its relative valuation, which is a method of valuing Dreyfus/the Boston by comparing valuation metrics with similar companies.
Peers
Dreyfus/the Boston Related Equities
RYHCX | Health Care | 0.63 | ||||
RAGHX | Allianzgi Health | 0.38 | ||||
GGHYX | Invesco Global | 0.22 | ||||
FHCCX | Fidelity Advisor | 0.14 | ||||
ETAHX | Eventide Healthcare | 0.17 |
Other Information on Investing in Dreyfus/the Mutual Fund
Dreyfus/the Boston financial ratios help investors to determine whether Dreyfus/the Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfus/the with respect to the benefits of owning Dreyfus/the Boston security.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |